comparemela.com

Latest Breaking News On - Victoria whyte - Page 1 : comparemela.com

GSK : THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE, TRANSMISSION DISTRIBUTION OR FORWARDING, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF SECURITIES IN ANY JURISDICTION - Form 6-K -October 06, 2023 at 02:22 pm EDT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER.

United kingdomUnited statesUnited kingdom generalCity ofTim foleyNick stoneKathleen quinnCamilla campbellMick readeySarah clementsJames dodwellLyndsay meyerSteph mountifieldJeff mclaughlinJosh williamsSecurities exchange

GSK : Current Report Of Foreign Issuer - Form 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE. | May 12, 2023

City ofUnited kingdomUnited statesUnited kingdom generalCamilla campbellNick stoneJeff mclaughlinSimon mooreMick readeyJames dodwellTim foleySteph mountifieldKathleen quinnJoshua williamsPfizer incPrudential regulatory authority

Board information

Board information

United kingdomUnited kingdom generalEmma walmsleyCharles bancroftJonathan symondsHal barronLeadership teamAudit risk committeeGovernance instituteBoard committeeOur companyExecutive directorsBoard directorCompany secretaryVictoria whyteChartered governance institute

Investegate |GlaxoSK Capital PLC Announcements | GlaxoSK Capital PLC: EMTN Notes repurchase results

Investegate announcements from GlaxoSK Capital PLC, EMTN Notes repurchase results

United kingdomUnited kingdom generalGroup euro medium term note programmeIt forms part of united kingdomGlaxosmithkline capitalplc the companyCompany secretarySmithkline capitalSmithkline capitalplcEuro medium term note programmeNominal amount outstandingGlaxosmithkline capitalVictoria whyteInvestegate announcementsInvestegate company announcementsLaxosk capital plcEgulatory news service

Investegate |GSK PLC Announcements | GSK PLC: Positive phase III data for GSK s RSV OA vaccine

Investegate announcements from GSK PLC, Positive phase III data for GSK s RSV OA vaccine

United kingdomUnited statesCity ofUnited kingdom generalSimon mooreKathleen quinnJosh williamsJeff mclaughlinSonya ghobrialMick readeyLyndsay meyerTim foleyJames dodwellHal barronNick stoneCompany secretary

vimarsana © 2020. All Rights Reserved.